Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VNRX
VNRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VNRX News
VolitionRx Launches rNuQ Webshop to Expand Product Line
1d ago
Newsfilter
VolitionRX Reports 133% Revenue Growth in Q4 2025
Apr 03 2026
Yahoo Finance
VolitionRx Q4 2025 Earnings Call Highlights
Apr 01 2026
seekingalpha
VolitionRX Reports 40% Revenue Growth in FY
Apr 01 2026
seekingalpha
VolitionRx Secures €2 Million Non-Dilutive Financing
Mar 31 2026
seekingalpha
Nu.Q® Biomarkers Clinical Study Published in Shock Journal
Mar 30 2026
Newsfilter
VolitionRx to Host Earnings Call on April 1, 2026
Mar 25 2026
Newsfilter
VolitionRx's Breakthrough Liquid Biopsy Technology Achieves High Detection Rates
Mar 25 2026
NASDAQ.COM
VolitionRx Achieves Breakthrough with New Liquid Biopsy Method
Mar 25 2026
stocktwits
VNRX Shares Jump 34% in Pre-Market Trading — What’s Fueling the Surge?
Mar 25 2026
stocktwits
VolitionRx Shares Surge 70% on Breakthrough in Cancer Detection
Mar 18 2026
stocktwits
VolitionRx Unveils New Cancer Detection Technology
Mar 18 2026
Newsfilter
VolitionRx Completes Validation of Nu.Q® Vet Cancer Test with Fujifilm
Mar 06 2026
Newsfilter
VolitionRx Receives NYSE Compliance Notice
Feb 09 2026
seekingalpha
Venus Concept Inc. Announces Voluntary Delisting from NASDAQ to Cut Compliance Costs
Jan 21 2026
Globenewswire
VolitionRx Expands Nu.Q® Vet Cancer Test Access in U.S. and Asia
Jan 20 2026
PRnewswire
Show More News
